Europe Vaginal Health Probiotic Supplements Market Size
Europe vaginal health probiotic supplements market was US$91.51 million in 2024 and is expected to reach US$165.80 million in 2032, growing at a CAGR of 7.8% during the forecast period 2025-2032.
Europe vaginal health probiotic supplements market is expanding steadily as women turn to natural solutions for intimate and overall wellness. Rising awareness of microbiota health is a key driver, with probiotics increasingly recognized for benefits beyond digestion. According to the International Probiotics Association – Europe (IPA Europe), awareness now reaches 63% of consumers, with men and women consuming probiotics almost equally, while uptake peaks among adults aged 25–44, a group highly engaged in preventive healthcare.
Demographics further strengthen demand, for instance, the European Commission reports women make up 191 million people or 51.2% of the EU population, with longevity playing a role since there are 221 women for every 100 men at age 80, ensuring sustained demand in midlife and senior health categories. In line with these dynamics, innovation is diversifying. For example, in August 2025, UK-based ProBiotix Health launched Your BiotixMH and Your BiotixPMH, supplements for menopause and post-menopause.
Vaginal Health Probiotic Supplements Industry Trends and Strategic Insights
Germanydominates the market in the market, capturing the largest revenue share of 16.88% in 2024.
By type, oral supplements is projected to experience the largest market, registering a significant 70.83% in 2024.
Market Size and Future Outlook
2024 Market Size:US$91.81 Million
2032 Projected Market Size: US$165.80 Million
CAGR (2025-2032): 7.8%
Largest Market: Germany
Fastest Market: Spain
Source: DataM Intelligence Email: [email protected]
Market Scope
Metrics | Details |
By Form | Oral Supplements, Topical Supplements |
By Application | Bacterial Vaginosis (BV) Prevention & Treatment, Menopause Support and Healthy Ageing, Infection Prevention & Vaginal Microbiome Support, Urinary Tract Health & Vaginal pH Balance, General Vaginal Health & Hygiene |
By End-User | Pre-Menopausal Women, Peri-Menopausal Women, Post-Menopausal Women |
By Country | Germany, UK, France, Italy, Spain and Rest of Europe |
Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth |
Market Dynamics
High Prevalence of Vaginal and Urinary Tract Infections (UTIs)
The high prevalence of vaginal and urinary tract infections (UTIs) is becoming one of the strongest forces shaping the growth of Europe’s vaginal health probiotic supplements market. Millions of women across the region continue to face bacterial vaginosis, yeast infections and recurrent UTIs, which create discomfort, social stigma and significant healthcare costs. According to the UK Government’s Hospital Episode Statistics (HES) data, England alone recorded 189,756 UTI hospital admissions in FY 2023–24, resulting in 1.2 million NHS bed-days. Admissions increased by 9% compared to the previous year, showing that the burden of infection remains substantial.
Older adults remain particularly vulnerable, with 52.7% of UTI cases in patients aged 70+ and the highest admission rates recorded among those aged 90 and over, reaching 3,367 per 100,000 population. These figures highlight the strain that recurrent infections place not only on individuals but also on public health systems. At the same time, younger women are not exempt from infection risks.
Moreover, according to the European Centre for Disease Prevention and Control (ECDC), chlamydia was the most frequently reported bacterial STI in Europe in 2023, with over 230,000 cases across EU/EEA countries. This marked a 13% increase since 2014, with women aged 20–24 years experiencing the highest rates.
Segmentation Analysis
Europe vaginal health probiotic supplements market is segmented based on form, application, end-user and country.
Oral Supplements Lead Europe Vaginal Health Probiotic Market Due to Ease of Use and Consumer Preference
Europe vaginal health probiotic supplements market for oral supplements was US$64.81 million in 2024 and is expected to reach US$116.86 million by 2032, growing with a CAGR of 7.7% between 2025 and 2032.
Oral vaginal probiotics are gaining momentum in Europe, fueled by convenience, accessibility and ease of daily use in women’s health routines. Capsules, tablets, gummies and powders dominate the segment as they are easy to use, shelf-stable and suitable for regular consumption. Consumers increasingly prefer non-invasive, self-administered options over topical or medical interventions. Daily-use oral probiotics allow women to integrate vaginal health care into their broader wellness routines, enhancing adoption.
Hence, the market is witnessing growing demand for convenient, daily-use oral supplements. For instance, in January 2024, Bayer Consumer Health launched Canes Biotics, a nutritional supplement for daily intimate care, containing four billion live cultures of Lactobacilli and Bifidobacterium, along with vitamin B2 to support vaginal mucosa and skin health.
Brands focusing on scientific validation and targeted strains are outperforming generic probiotic mixes. By February 2025, the UK market witnessed another innovation with Dr Megan Rossi’s Smart Strains, a next-generation probiotic range addressing the shortcomings of generic products by delivering clinically tested, targeted bacterial strains at precise doses. Smart Strains supports specific health goals, including antibiotic recovery, immune support, infant gut health and the vaginal microbiome, emphasizing the importance of correct strains, dosage and delivery format.
Topical Supplements are Gaining Traction Due to Convenience and Fast-Acting Benefits
Europe vaginal health probiotic supplements market for topical supplements was US$26.70 million in 2024 and is expected to reach US$48.94 million by 2032, growing with a CAGR of 7.9% between 2025 and 2032.
Tropical Supplements has emerged as a key segment in the European vaginal health probiotic supplements market by strategically addressing women’s wellness needs across multiple product formats. The company’s portfolio includes capsules, vaginal gels and vaginal suppositories, catering to both preventive and therapeutic requirements. Europe’s rising awareness of intimate health has driven demand for clinically backed probiotics, creating an opportunity that Tropical Supplements has leveraged through robust research and development.
For instance, in August 2023, the launch of Gynoflorelle by Medinova AG in partnership with Belgian biotech YUN N.V. highlighted the growing consumer preference for microbiome-friendly, two-step intimate care routines. Tropical Supplements responded by innovating its own formulations that complement such routines, ensuring protection, restoration and support of the vaginal microbiome. The brand emphasizes live lactobacilli strains in its gels and suppositories, aligning with scientific evidence that supports vaginal flora balance and infection prevention. By collaborating with healthcare professionals, the company has strengthened credibility and expanded its recommendation network across Germany, Switzerland and other key European markets.
Regional Penetration
Germany Holds Major Share in Europe Vaginal Health Probiotics Market Driven by High Awareness and Advanced Healthcare Infrastructure
Germany Vaginal Health Probiotic supplements market was valued at US$ 15.45 million in 2024 and is estimated to reach US$ 26.46 million by 2032, growing at a CAGR of 7.0% during the forecast period from 2025-2032.
Germany commands a significant share in the European vaginal probiotic supplements market, driven by a mix of economic strength, healthcare leadership and consumer awareness. According to Eurostat, Germany accounted for 25.6% of the EU’s gross household adjusted disposable income, the highest in the bloc, reflecting both purchasing power and capacity to invest in premium women’s health products. This strong economic foundation has translated into higher adoption of probiotic supplements, particularly those targeting intimate and vaginal health, where demand is rising for clinically validated and natural solutions.
Adding to this momentum, product innovation has been central to Germany’s market growth. In August 2023, Medinova AG, a Swiss women’s health specialist, in partnership with Belgian biotech YUN Probiotherapy, introduced Gynoflorelle in Germany and Switzerland. This pioneering brand, based on a two-step routine of prebiotic wash and probiotic gel, focuses on strengthening and restoring the vaginal microbiome across life stages, from pregnancy to menopause. With clinically proven lactobacilli strains, the brand addresses unmet needs in intimate care, positioning Germany at the forefront of next-generation vaginal probiotic solutions in Europe.
Spain Captures Growing Share Fueled by Rising Women’s Health Awareness and Expanding Access to Supplements
Spain vaginal health probiotic supplements market was valued at US$ 5.95 million in 2024 and is estimated to reach US$ 12.53 million by 2032, growing at a CAGR of 9.8% during the forecast period from 2025-2032.
The demand for vaginal-health probiotic supplements in Spain is expanding, largely due to measurable infection prevalence and high recurrence rates that underscore the need for preventive care. Clinical evidence shows that Candida species account for about one-quarter of yeast cultures from Spanish women, while regional epidemiological studies, such as those in Granada, report candidiasis prevalence in the mid-teens among women attending clinics.
Recurrent bacterial vaginosis (BV) further amplifies demand. Spanish clinical audits confirm that many women with vaginal complaints report prior episodes, reflecting global relapse rates of 50–60 percent within twelve months. Such recurrence patterns transform BV from an acute to a chronic condition, creating ongoing need for adjunctive options like probiotics that aim to reduce relapse risk and sustain Lactobacillus-dominant vaginal ecosystems. Spain also benefits from a strong consumer culture around supplements. National health surveys and sector analyses show that approximately 70–75 percent of Spaniards report supplement usage. This normalization of supplement routines lowers barriers for women to adopt vaginal probiotics, particularly when positioned as daily maintenance products
Consumer Analysis
Europe vaginal health probiotic supplements market is witnessing strong growth, fueled by rising health consciousness among women. Daily intake patterns highlight deep commitment, with an IFIC survey showing 35% of women consume probiotics once daily and 20% multiple times a day. Together, daily users make up 55% of the market, while another 27% use them a few times per week, demonstrating sustained engagement.
Smaller segments, 2% once a week, 9% a few times per month and 6% less than once a month, represent occasional users who are open to integrating probiotics into their lifestyles. Women show clear preferences for familiar formats: 55% consume yogurt, 37% take regular probiotics, 22% rely on fermented foods and 8% choose synbiotics. This mix indicates both habitual and exploratory consumption patterns.
Similarly, nutritional supplement use is more common among adults aged 19 and over (47.3%) than among children and youth (38.5%). Women are more likely than men to take supplements, especially those aged 51–70, where 65.1% of women use them compared to 42.5% of men. Social media and influencers play a key role in shaping perceptions, educating women and driving the adoption of new products. Consumers are increasingly seeking personalized solutions tailored to vaginal health, menopause and overall feminine wellness
Competitive Landscape
The European vaginal health probiotic supplement market is highly fragmented, with key players competing for share. Canesten (Bayer) leverages its established brand authority in feminine care for significant market presence. Garden of Life (Nestlé) utilizes its vast distribution network and trusted wellness reputation.
DR. VEGAN and Physician's Choice are strong digitally-native brands capturing the growing e-commerce and conscious consumer segments. APYFORME, Laboratoire CCD, Synformulas GmbH and Wellgard hold notable shares through targeted online strategies and pharmacy placements.
Farmacia Dottor Tili and Novomins Nutrition represent important, smaller regional players, often competing on specialized formulations and local trust within the Italian and broader European markets.
Key Developments
In January 2024, Lemme launched a capsule version of its bestselling Lemme Purr gummies, expanding its lineup of women’s health products. The new capsules, clinically formulated to support vaginal pH balance, odor control, taste and overall vaginal and urinary tract health, follow high demand and multiple sell-outs of the gummy version.
Why Choose DataM?
Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth countries.
Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
